{"filing":{"accession_number":"0001140361-26-028763","cik":"0000320017","ticker":"LSTA","company_name":"LISATA THERAPEUTICS, INC.","form":"8-K","filing_date":"2026-07-17","report_date":null,"primary_document":"ef20078184_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/320017/000114036126028763/ef20078184_8k.htm"},"events":[{"id":18570,"run_id":16695,"accession_number":"0001140361-26-028763","anchor_item_number":"1.01","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.95,"summary":"The filing discloses an amendment to a previously announced merger agreement between Lisata Therapeutics and Kuva Labs Inc., extending the Outside Date from July 17, 2026 to July 21, 2026. This is a material modification to an existing M\u0026A transaction that would affect a reasonable investor's assessment of the deal's status and timeline.","company_name":"LISATA THERAPEUTICS, INC.","ticker":"LSTA","filing_date":"2026-07-17","form":"8-K","submitted_at":null,"items":[{"id":17415,"accession_number":"0001140361-26-028763","item_number":"1.01","item_title":null,"event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.95,"reasoning":"The filing discloses an amendment to a previously announced merger agreement between Lisata Therapeutics and Kuva Labs Inc., extending the Outside Date from July 17, 2026 to July 21, 2026. This is a material modification to an existing M\u0026A transaction that would affect a reasonable investor's assessment of the deal's status and timeline.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-17T11:02:35.595344+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":17415,"accession_number":"0001140361-26-028763","item_number":"1.01","item_title":null,"event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.95,"reasoning":"The filing discloses an amendment to a previously announced merger agreement between Lisata Therapeutics and Kuva Labs Inc., extending the Outside Date from July 17, 2026 to July 21, 2026. This is a material modification to an existing M\u0026A transaction that would affect a reasonable investor's assessment of the deal's status and timeline.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-17T11:02:35.595344+00:00","company_name":"LISATA THERAPEUTICS, INC.","ticker":"LSTA","filing_date":"2026-07-17"}]}